Evoke Pharma Inc (EVOK) Stock

DelistedNasdaq: EVOKEvoke Pharma, Inc.

10.93
Final close · Dec 5, 2025

EVOK is no longer traded. Evoke Pharma was delisted from the Nasdaq in December 2025.

Prices on this page are historical; the last trade was December 5, 2025 at $10.93.

Evoke Pharma stock price history

Split-adjusted closes, 2013–2025

EVOK final trading statistics

Final close
$10.93
Final trading day
Dec 5, 2025
Market cap at delisting
$18.83M
Shares outstanding
1.72M
Final 52-week range
$1.94 – $10.94
Avg. volume (final 3 mo.)
94,940
All-time high (split-adj.)
$2014.56 · Oct 2013
All-time low (split-adj.)
$2.07 · Apr 2025
Return since IPO
-99.4%
Beta
-0.14
Book value / share
$1.56
Price / book
7.01
Final 52 wk
1.9410.94

Evoke Pharma earnings per share

Earnings per share

Evoke Pharma revenue & net income

RevenueNet income

Evoke Pharma annual financials

Fiscal yearRevenueNet incomeEPS
FY2024$10.25M-$5.4M-$2.81
FY2023$5.18M-$7.8M-$2.33
FY2022$2.51M-$8.2M-$2.68
FY2021$1.62M-$8.5M-$3.24
FY2020$23.0K-$13.2M-$6.24

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Evoke Pharma Inc

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.

Evoke Pharma stock FAQ

What happened to Evoke Pharma stock?

Evoke Pharma stock was delisted from the Nasdaq. Its final close was $10.93 on December 5, 2025.

Is EVOK stock still trading?

No. EVOK was delisted from the Nasdaq in December 2025 and no longer trades on a U.S. exchange.

What was the last price of EVOK stock?

EVOK closed at $10.93 on its final trading day, December 5, 2025, for a market value of about $18.83M.

What were Evoke Pharma's revenue and earnings in its last full fiscal year?

Evoke Pharma reported revenue of $10.25M and net income of -$5.4M in fiscal 2024, its last full year as a public company.

When did Evoke Pharma go public?

Evoke Pharma Inc stock began trading on September 25, 2013.

Drug Manufacturers - Specialty & Generic stocks to research

All Healthcare stocks →